Evidence-Based Medicine Guidelines
Trifluoperazine for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Trifluoperazine for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456552/all/Trifluoperazine_for_schizophrenia.
Trifluoperazine for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/456552/all/Trifluoperazine_for_schizophrenia. Accessed November 7, 2024.
Trifluoperazine for schizophrenia. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456552/all/Trifluoperazine_for_schizophrenia
Trifluoperazine for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456552/all/Trifluoperazine_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Trifluoperazine for schizophrenia
ID - 456552
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456552/all/Trifluoperazine_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
